Trial Participation in Neurodegenerative Diseases: Barriers and Facilitators: A Systematic Review and Meta-Analysis.

Daphne N Weemering Anita BeelenTessa KliestLucie A G van LeeuwenLeonard H van den Berg Ruben P A van Eijk

Published in: Neurology (2024)

We have provided a comprehensive list of reasons why patients participate in clinical trials for neurodegenerative diseases. These results may help to increase participation rates, better inform patients, and facilitate patient-centric approaches, thereby potentially reducing selection mechanisms and improving generalizability of trial results.

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
physical activity
study protocol
phase iii
phase ii
open label